Prof Marco Gerlinger

Professor Marco Gerlinger, MD FRCP, specialises in the treatment of patients with bowel, stomach and oesophageal cancers at LOC Harley Street, The Harley Street Clinic and Nuffield St Barts. He is a Consultant Medical Oncologist, Chair of Gastrointestinal Cancer Medicine, and the Director of GI Cancer Research at St Bartholomew's Hospital and Queen Mary University of London. Prof Gerlinger studied Medicine at the University of Munich, Harvard Medical School and Imperial College and obtained his research MD from the Institute of Immunology in Munich. He trained in General Medicine and Medical Oncology in Zurich and London and undertook post-doctoral research training in Zurich and at the CRUK London Research Institute (now The Francis Crick Institute). In 2013, Prof Gerlinger joined the Royal Marsden Hospital as a consultant in GI cancer and the Institute of Cancer Research as a research team leader. He was subsequently appointed at St Bartholomew's Hospital and Queen Mary University in 2022. With his clinical and research teams, he leads clinical trials and develops precision medicines including antibody drug conjugates and immunotherapies for colorectal, stomach and oesophageal cancers. Prof Gerlinger has served as faculty member for the largest international oncology meetings including the American Society of Clinical Oncology Annual Meetings and the European Society of Medical Oncology Annual Meetings. He has furthermore served twice on the ESMO Annual Meeting lower GI cancer track Scientific Committee and is one of the few Europeans who served as track chair on the American Association of Cancer Research Annual Meeting. He has been awarded multiple prestigious research grants from the European Commission, Cancer Research UK, the UK Medical Research Council and the National Institute of Health Research.

"Evidence-based care tailored to each patient — taking the time to explain options and shared decisions."

1. 2003–2009
   MD · Medicine and Surgery

   Universitat de València

2. 2009–2013
   Residency · Oncology

   Universitat de Barcelona

1. 2013-09–2014-08
   Junior consultant

   Universitat de València Teaching Hospital — Oncology

1. 1 Choose a slot
2. 2 Brief pre-consult form
3. 3 Consultation
4. 4 Follow-up note & plan

Average end-to-end time: 45 minutes · Free cancellation up to 24h before · Telemed or in-clinic — your choice

h-index: 10 · i10: 10

Selected publications

1. Validation of clinical scoring in Oncology

   Prof Marco Gerlinger, et al. · European Journal of Medicine, 2026

   DOI: 10.3731/euroclin.2026.0 · cited by 18

2. Long-term follow-up of Oncology across

   Prof Marco Gerlinger, et al. · European Journal of Medicine, 2025

   DOI: 10.6968/euroclin.2025.1 · cited by 64

• Patient education Patient guide to Oncology 2026-03-05 · 4 min read
• Awareness When should you see a oncology? 2026-01-08 · 10 min read